Annual Retained Earnings
-$3.10 B
-$535.76 M-20.92%
December 31, 2024
Summary
- As of February 27, 2025, BBIO annual retained earnings is -$3.10 billion, with the most recent change of -$535.76 million (-20.92%) on December 31, 2024.
- During the last 3 years, BBIO annual retained earnings has fallen by -$1.66 billion (-115.47%).
- BBIO annual retained earnings is now -4940.56% below its all-time high of -$61.43 million, reached on December 31, 2017.
Performance
BBIO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$3.10 B
-$265.05 M-9.36%
December 31, 2024
Summary
- As of February 27, 2025, BBIO quarterly retained earnings is -$3.10 billion, with the most recent change of -$265.05 million (-9.36%) on December 31, 2024.
- Over the past year, BBIO quarterly retained earnings has dropped by -$265.05 million (-9.36%).
- BBIO quarterly retained earnings is now -1625.48% below its all-time high of -$179.44 million, reached on December 31, 2018.
Performance
BBIO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
BBIO Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.9% | -9.4% |
| 3 y3 years | -115.5% | -9.4% |
| 5 y5 years | -603.6% | -9.4% |
BBIO Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -115.5% | at low | -115.5% | at low |
| 5 y | 5-year | -603.6% | at low | -603.6% | at low |
| alltime | all time | -4940.6% | at low | -1625.5% | at low |
BridgeBio Pharma Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$3.10 B(+20.9%) | -$3.10 B(+9.4%) |
| Sep 2024 | - | -$2.83 B(+6.1%) |
| Jun 2024 | - | -$2.67 B(+2.8%) |
| Mar 2024 | - | -$2.60 B(+1.4%) |
| Dec 2023 | -$2.56 B(+33.5%) | -$2.56 B(+7.0%) |
| Sep 2023 | - | -$2.39 B(+8.0%) |
| Jun 2023 | - | -$2.22 B(+7.7%) |
| Mar 2023 | - | -$2.06 B(+7.3%) |
| Dec 2022 | -$1.92 B(+33.5%) | -$1.92 B(+7.7%) |
| Sep 2022 | - | -$1.78 B(+8.4%) |
| Jun 2022 | - | -$1.64 B(+0.6%) |
| Mar 2022 | - | -$1.63 B(+13.7%) |
| Dec 2021 | -$1.44 B | -$1.44 B(+11.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | -$1.29 B(+13.8%) |
| Jun 2021 | - | -$1.13 B(+9.3%) |
| Mar 2021 | - | -$1.04 B(+16.7%) |
| Dec 2020 | -$888.75 M(+102.0%) | -$888.75 M(+15.6%) |
| Sep 2020 | - | -$768.77 M(+17.7%) |
| Jun 2020 | - | -$652.91 M(+22.8%) |
| Mar 2020 | - | -$531.88 M(+20.9%) |
| Dec 2019 | -$440.03 M(+145.2%) | -$440.03 M(+20.0%) |
| Sep 2019 | - | -$366.57 M(+12.4%) |
| Jun 2019 | - | -$326.07 M(+38.9%) |
| Mar 2019 | - | -$234.73 M(+30.8%) |
| Dec 2018 | -$179.44 M(+192.1%) | -$179.44 M |
| Dec 2017 | -$61.43 M | - |
FAQ
- What is BridgeBio Pharma annual retained earnings?
- What is the all time high annual retained earnings for BridgeBio Pharma?
- What is BridgeBio Pharma annual retained earnings year-on-year change?
- What is BridgeBio Pharma quarterly retained earnings?
- What is the all time high quarterly retained earnings for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly retained earnings year-on-year change?
What is BridgeBio Pharma annual retained earnings?
The current annual retained earnings of BBIO is -$3.10 B
What is the all time high annual retained earnings for BridgeBio Pharma?
BridgeBio Pharma all-time high annual retained earnings is -$61.43 M
What is BridgeBio Pharma annual retained earnings year-on-year change?
Over the past year, BBIO annual retained earnings has changed by -$535.76 M (-20.92%)
What is BridgeBio Pharma quarterly retained earnings?
The current quarterly retained earnings of BBIO is -$3.10 B
What is the all time high quarterly retained earnings for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly retained earnings is -$179.44 M
What is BridgeBio Pharma quarterly retained earnings year-on-year change?
Over the past year, BBIO quarterly retained earnings has changed by -$265.05 M (-9.36%)